Alector, Inc. (ALEC) Financials
ALEC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 621.8 million | 487.7 million |
2023-09-30 | 672.4 million | 509.8 million |
2023-06-30 | 708.7 million | 512.4 million |
2023-03-31 | 748.3 million | 565.3 million |
ALEC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -46.3 million | 11.5 million |
2023-09-30 | -46.4 million | 10.1 million |
2023-06-30 | -44.2 million | 10.2 million |
2023-03-31 | -49.6 million | 11.0 million |
ALEC Net Income
No data available :(
ALEC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 548.9 million | - | 38.9 million |
2023-09-30 | 588.9 million | - | 40.2 million |
2023-06-30 | 630.0 million | - | 40.9 million |
2023-03-31 | 669.3 million | - | 42.2 million |
ALEC Shares Outstanding
ALEC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 233000 | 47.7 million | 14.9 million | - |
2023-09-30 | 94000 | 46.3 million | 13.4 million | - |
2023-06-30 | 1.2 million | 46.2 million | 13.6 million | - |
2023-03-31 | 1.0 million | 51.9 million | 14.8 million | - |
ALEC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 15.2 million | 6.6 million |
2023-09-30 | 9.1 million | 2.3 million |
2023-06-30 | 56.2 million | 2.2 million |
2023-03-31 | 16.5 million | 2.1 million |
ALEC
Price: $5.39
52 week price:
Earnings Per Share: -1.56 USD
P/E Ratio: -3.41
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 209662
Market Capitalization: 519.5 million